Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Piotr Rutkowski et al.|New England Journal of Medicine|2021Cited by 869
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitorBrendan D. Curti, William L. Redmond|Journal for ImmunoTherapy of Cancer|2021Cited by 94